序号 专利名 申请号 申请日 公开(公告)号 公开(公告)日 发明人
1 Human cytidine monophosphate (cmp) kinase cdna US10362332 2001-08-15 US20050100998A1 2005-05-12 Stephen Prescott; A. Pearman; Hugo Castro-Faria-Neto; Diana Stafforini; Thomas McIntyre
The present invention provides the cDNA for a novel nucleoside/nucleotide monophosphate kinase cloned from a human macrophage cDNA library. This kinase is able to phosphorylate UMP and utilize multiple phosphate donors, but has demonstrated a preference for transferring a phosphate from ATP or UTP to cytidine monophosphate (CTP). The kinase is thus referred to as cytidine monophosphate (CMP) kinase. This kinase is shown to be a Mg2+ dependent nucleotide kinase which codes for two ubiquitously transcribed mRNA splice products of 3.2 and 2.0 kb, and has been mapped to chromosome 1, region p32-34.1, a region known to contain other nucleotide modifying enzyme genes.
2 Modulating the Rad-nm23 interaction US10074694 2002-02-12 US20030013673A1 2003-01-16 C. Ronald Kahn; Jianhua Zhu
The present invention is based on the discovery of a novel bimolecular, bidirectional mechanism of regulation between nm23 and Rad. Accordingly, the present invention provides a method of modulating an activity of nm23 in a subject at risk for a proliferative disorder, comprising: modulating the level of Rad activity.
3 Hitoshichijin monophosphate (CMP) kinase cDNA JP2002521474 2001-08-15 JP2004506440A 2004-03-04 カストロ−ファリア−ネト、ヒューゴ; スタッフォリーニ、ダイアナ; ピアマン、テラス; プレスコット、スティーブン; マッキンタイア、トーマス
本発明は、ヒトマクロファージcDNAライブラリからクローニングされた新規なヌクレオシド/ヌクレオチド一リン酸キナーゼcDNAを提供する。 このキナーゼは、UMPをリン酸化し、多くのリン酸供与体を利用することができるが、リン酸をATPまたはUTPからシチジン一リン酸(CMP)に転移させる選択性を示した。 したがって、このキナーゼはシチジン一リン酸(CMP)キナーゼと称される。 このキナーゼは、3.2kbと2.0kbの2種の遍在的に転写されるmRNAスプライス産物をコードするMg 2+依存性ヌクレオチドキナーゼであることが示され、他のヌクレオチド修飾酵素遺伝子を含むことが知られている領域である1番染色体のp32〜34.1領域にマッピングされた。
4 HUMAN CYTIDINE MONOPHOSPHATE (CMP) KINASE CDNA EP01967986.9 2001-08-15 EP1311528A2 2003-05-21 PRESCOTT, Stephen; PEARMAN, Terrece; CASTRO-FARIA-NETO, HugoHuntsman Cancer Institute; STAFFORINI, Diana; MCINTYRE, Thomas
The present invention provides the cDNA for a novel nucleoside/nucleotide monophosphate kinase cloned from a human macrophage cDNA library. This kinase is able to phosphorylate UMP and utilize multiple phosphate donors, but has demonstrated a preference for transferring a phosphate from ATP or UTP to cytidine monophosphate (CMP). The kinase is thus referred to as cytidine monophosphate (CMP) kinase. This kinase is shown to be a Mg2+ dependent nucleotide kinase which codes for two ubiquitously transcribed mRNA splice products of 3.2 and 2.0 kb, and has been mapped to chromosome 1, region p32-34.1, a region known to contain other nucleotide modifying enzyme genes.
5 HUMAN CYTIDINE MONOPHOSPHATE (CMP) KINASE CDNA PCT/US0125567 2001-08-15 WO0216377A3 2002-05-10 PRESCOTT STEPHEN; PEARMAN TERRECE; CASTRO-FARIA-NETO HUGO; STAFFORINI DIANA; MCINTYRE THOMAS
The present invention provides the cDNA for a novel nucleoside/nucleotide monophosphate kinase cloned from a human macrophage cDNA library. This kinase is able to phosphorylate UMP and utilize multiple phosphate donors, but has demonstrated a preference for transferring a phosphate from ATP or UTP to cytidine monophosphate (CMP). The kinase is thus referred to as cytidine monophosphate (CMP) kinase. This kinase is shown to be a Mg2+ dependent nucleotide kinase which codes for two ubiquitously transcribed mRNA splice products of 3.2 and 2.0 kb, and has been mapped to chromosome 1, region p32-34.1, a region known to contain other nucleotide modifying enzyme genes.
6 MODULATING THE RAD-NM23 INTERACTION PCT/US9806521 1998-04-02 WO9844088A3 1999-02-25 KAHN C RONALD; ZHU JINHUA
The present invention is based on the discovery of a novel bimolecular, bi-directional mechanism of regulation between nm23 and Rad. Accordingly, the present invention provides a method of modulating an activity of nm23 in a subject at risk for a proliferative disorder, comprising: modulating the level of Rad activity.
QQ群二维码
意见反馈